多西紫杉醇
医学
内科学
肿瘤科
打开标签
随机对照试验
化疗
作者
Caicun Zhou,Dingzhi Huang,Yun Fan,Xinmin Yu,Yunpeng Liu,Yongqian Shu,Zhiyong Ma,Ziping Wang,Ying Cheng,Jie Wang,Sheng Hu,Zhihua Liu,Elena Poddubskaya,Umut Dişel,А. Л. Акопов,Mikhail Dvorkin,Wenjuan Zheng,Yiyuan Ma,Yan Wang,Songzi Li
标识
DOI：10.1016/j.jtho.2022.09.217
摘要
Tislelizumab was found to have a significantly improved and long-term clinical benefit in OS versus docetaxel in pretreated patients with advanced NSCLC, regardless of PD-L1 expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
贪玩的秋柔
大力的灵雁
嘉心糖
殷勤的紫槐
如意小兔子
Riverchase
无极微光
xzy998
wanci
Maestro_S
海蓝云天
Semy
小太阳在营业
厨博士
科研狗
11235
ephore
乐空思
pluto
皖公网安备34019202002308
